Comparison of SBRT and SIRT With Combination IO for Locally-advanced, Unresectable HCCs (BIIRTH)

NCT07293468 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

106

Enrollment

OTHER_GOV

Sponsor class

Conditions

Hepatocellular Carcinoma (HCC)

Interventions

PROCEDURE: Transarterial chemoembolization (TACE)
RADIATION: Stereotactic Body Radiation Therapy (SBRT)
RADIATION: SIRT Yttrium-90
DRUG: Atezolizumab & Bevacizumab

Sponsor

Tuen Mun Hospital

Collaborators

[object Object]
[object Object]
[object Object]